nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—Alkylating Activity—Dacarbazine—pancreatic cancer	0.798	1	CiPCiCtD
Carmustine—CYP1A2—Dacarbazine—pancreatic cancer	0.0293	0.327	CbGbCtD
Carmustine—CYP1A2—Tamoxifen—pancreatic cancer	0.0233	0.26	CbGbCtD
Carmustine—CYP1A2—Erlotinib—pancreatic cancer	0.0198	0.221	CbGbCtD
Carmustine—CYP1A2—Fluorouracil—pancreatic cancer	0.0172	0.192	CbGbCtD
Carmustine—GSR—NRF2 pathway—FGF13—pancreatic cancer	0.000966	0.12	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—NFE2L2—pancreatic cancer	0.00096	0.119	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—SOD2—pancreatic cancer	0.000581	0.072	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—TYMP—pancreatic cancer	0.000555	0.0687	CbGpPWpGaD
Carmustine—GSR—Oxidative Stress—SOD2—pancreatic cancer	0.000534	0.0661	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—DPYD—pancreatic cancer	0.00044	0.0545	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—NFE2L2—pancreatic cancer	0.000271	0.0335	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFA—pancreatic cancer	0.000258	0.032	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—SLC2A2—pancreatic cancer	0.000253	0.0313	CbGpPWpGaD
Carmustine—GSR—Nucleotide metabolism—TYMS—pancreatic cancer	0.000251	0.031	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—SOD2—pancreatic cancer	0.000226	0.028	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—HSPA1A—pancreatic cancer	0.000194	0.0241	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—HSPA1B—pancreatic cancer	0.000143	0.0177	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—EZH2—pancreatic cancer	0.000131	0.0162	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—pancreatic cancer	0.000127	0.0157	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—HSPA1A—pancreatic cancer	0.000121	0.015	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—SOD2—pancreatic cancer	9.38e-05	0.0116	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—AHR—pancreatic cancer	8.62e-05	0.0107	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—AHR—pancreatic cancer	8.62e-05	0.0107	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—TNF—pancreatic cancer	8.56e-05	0.0106	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—NFE2L2—pancreatic cancer	8.4e-05	0.0104	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NFE2L2—pancreatic cancer	8.4e-05	0.0104	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—HIF1A—pancreatic cancer	7.87e-05	0.00975	CbGpPWpGaD
Carmustine—Paraesthesia—Irinotecan—pancreatic cancer	7.5e-05	0.00072	CcSEcCtD
Carmustine—Hypotension—Fluorouracil—pancreatic cancer	7.48e-05	0.000718	CcSEcCtD
Carmustine—Hypersensitivity—Sunitinib—pancreatic cancer	7.47e-05	0.000717	CcSEcCtD
Carmustine—Rash—Tamoxifen—pancreatic cancer	7.47e-05	0.000717	CcSEcCtD
Carmustine—Dermatitis—Tamoxifen—pancreatic cancer	7.46e-05	0.000716	CcSEcCtD
Carmustine—Ataxia—Epirubicin—pancreatic cancer	7.45e-05	0.000715	CcSEcCtD
Carmustine—Vomiting—Erlotinib—pancreatic cancer	7.45e-05	0.000715	CcSEcCtD
Carmustine—Dyspnoea—Irinotecan—pancreatic cancer	7.45e-05	0.000715	CcSEcCtD
Carmustine—Somnolence—Irinotecan—pancreatic cancer	7.43e-05	0.000713	CcSEcCtD
Carmustine—Headache—Tamoxifen—pancreatic cancer	7.42e-05	0.000712	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	7.41e-05	0.000712	CcSEcCtD
Carmustine—Rash—Erlotinib—pancreatic cancer	7.39e-05	0.000709	CcSEcCtD
Carmustine—Dermatitis—Erlotinib—pancreatic cancer	7.38e-05	0.000708	CcSEcCtD
Carmustine—Hyponatraemia—Doxorubicin—pancreatic cancer	7.36e-05	0.000707	CcSEcCtD
Carmustine—Insomnia—Gemcitabine—pancreatic cancer	7.36e-05	0.000706	CcSEcCtD
Carmustine—Headache—Erlotinib—pancreatic cancer	7.34e-05	0.000704	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—pancreatic cancer	7.33e-05	0.000704	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	7.33e-05	0.000704	CcSEcCtD
Carmustine—Liver function test abnormal—Epirubicin—pancreatic cancer	7.32e-05	0.000702	CcSEcCtD
Carmustine—Paraesthesia—Gemcitabine—pancreatic cancer	7.31e-05	0.000701	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	7.29e-05	0.0007	CcSEcCtD
Carmustine—Asthenia—Sunitinib—pancreatic cancer	7.28e-05	0.000698	CcSEcCtD
Carmustine—Decreased appetite—Irinotecan—pancreatic cancer	7.26e-05	0.000697	CcSEcCtD
Carmustine—Arrhythmia—Docetaxel—pancreatic cancer	7.26e-05	0.000697	CcSEcCtD
Carmustine—Dyspnoea—Gemcitabine—pancreatic cancer	7.25e-05	0.000696	CcSEcCtD
Carmustine—Insomnia—Fluorouracil—pancreatic cancer	7.24e-05	0.000695	CcSEcCtD
Carmustine—Somnolence—Gemcitabine—pancreatic cancer	7.23e-05	0.000694	CcSEcCtD
Carmustine—Hypokalaemia—Epirubicin—pancreatic cancer	7.21e-05	0.000692	CcSEcCtD
Carmustine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	7.21e-05	0.000692	CcSEcCtD
Carmustine—Paraesthesia—Fluorouracil—pancreatic cancer	7.18e-05	0.00069	CcSEcCtD
Carmustine—Alopecia—Docetaxel—pancreatic cancer	7.18e-05	0.000689	CcSEcCtD
Carmustine—Pain—Irinotecan—pancreatic cancer	7.14e-05	0.000686	CcSEcCtD
Carmustine—Constipation—Irinotecan—pancreatic cancer	7.14e-05	0.000686	CcSEcCtD
Carmustine—Dyspnoea—Fluorouracil—pancreatic cancer	7.13e-05	0.000685	CcSEcCtD
Carmustine—Mental disorder—Docetaxel—pancreatic cancer	7.12e-05	0.000684	CcSEcCtD
Carmustine—Somnolence—Fluorouracil—pancreatic cancer	7.11e-05	0.000683	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—pancreatic cancer	7.08e-05	0.000679	CcSEcCtD
Carmustine—Malnutrition—Docetaxel—pancreatic cancer	7.08e-05	0.000679	CcSEcCtD
Carmustine—Erythema—Docetaxel—pancreatic cancer	7.08e-05	0.000679	CcSEcCtD
Carmustine—Decreased appetite—Gemcitabine—pancreatic cancer	7.07e-05	0.000679	CcSEcCtD
Carmustine—Nausea—Tamoxifen—pancreatic cancer	7.03e-05	0.000675	CcSEcCtD
Carmustine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	7.03e-05	0.000674	CcSEcCtD
Carmustine—Muscular weakness—Epirubicin—pancreatic cancer	6.99e-05	0.000671	CcSEcCtD
Carmustine—Constipation—Gemcitabine—pancreatic cancer	6.96e-05	0.000668	CcSEcCtD
Carmustine—Pain—Gemcitabine—pancreatic cancer	6.96e-05	0.000668	CcSEcCtD
Carmustine—Nausea—Erlotinib—pancreatic cancer	6.96e-05	0.000668	CcSEcCtD
Carmustine—Decreased appetite—Fluorouracil—pancreatic cancer	6.96e-05	0.000668	CcSEcCtD
Carmustine—Diarrhoea—Sunitinib—pancreatic cancer	6.94e-05	0.000666	CcSEcCtD
Carmustine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	6.91e-05	0.000663	CcSEcCtD
Carmustine—Ataxia—Doxorubicin—pancreatic cancer	6.9e-05	0.000662	CcSEcCtD
Carmustine—Feeling abnormal—Irinotecan—pancreatic cancer	6.88e-05	0.000661	CcSEcCtD
Carmustine—Dysphagia—Epirubicin—pancreatic cancer	6.85e-05	0.000657	CcSEcCtD
Carmustine—Back pain—Docetaxel—pancreatic cancer	6.84e-05	0.000657	CcSEcCtD
Carmustine—Pain—Fluorouracil—pancreatic cancer	6.84e-05	0.000657	CcSEcCtD
Carmustine—Gastrointestinal pain—Irinotecan—pancreatic cancer	6.83e-05	0.000656	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—pancreatic cancer	6.77e-05	0.00065	CcSEcCtD
Carmustine—Dizziness—Sunitinib—pancreatic cancer	6.71e-05	0.000644	CcSEcCtD
Carmustine—Feeling abnormal—Gemcitabine—pancreatic cancer	6.71e-05	0.000644	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—pancreatic cancer	6.67e-05	0.000641	CcSEcCtD
Carmustine—GSR—Metabolism—PRSS1—pancreatic cancer	6.65e-05	0.00823	CbGpPWpGaD
Carmustine—Body temperature increased—Irinotecan—pancreatic cancer	6.6e-05	0.000634	CcSEcCtD
Carmustine—Abdominal pain—Irinotecan—pancreatic cancer	6.6e-05	0.000634	CcSEcCtD
Carmustine—Feeling abnormal—Fluorouracil—pancreatic cancer	6.59e-05	0.000633	CcSEcCtD
Carmustine—Anaemia—Docetaxel—pancreatic cancer	6.54e-05	0.000628	CcSEcCtD
Carmustine—Pancytopenia—Epirubicin—pancreatic cancer	6.5e-05	0.000624	CcSEcCtD
Carmustine—Muscular weakness—Doxorubicin—pancreatic cancer	6.47e-05	0.000621	CcSEcCtD
Carmustine—Vomiting—Sunitinib—pancreatic cancer	6.45e-05	0.000619	CcSEcCtD
Carmustine—Body temperature increased—Gemcitabine—pancreatic cancer	6.43e-05	0.000617	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—RB1—pancreatic cancer	6.41e-05	0.00793	CbGpPWpGaD
Carmustine—Neutropenia—Epirubicin—pancreatic cancer	6.41e-05	0.000615	CcSEcCtD
Carmustine—Rash—Sunitinib—pancreatic cancer	6.39e-05	0.000614	CcSEcCtD
Carmustine—Dermatitis—Sunitinib—pancreatic cancer	6.39e-05	0.000613	CcSEcCtD
Carmustine—Headache—Sunitinib—pancreatic cancer	6.35e-05	0.00061	CcSEcCtD
Carmustine—Dysphagia—Doxorubicin—pancreatic cancer	6.34e-05	0.000608	CcSEcCtD
Carmustine—Leukopenia—Docetaxel—pancreatic cancer	6.33e-05	0.000608	CcSEcCtD
Carmustine—Body temperature increased—Fluorouracil—pancreatic cancer	6.33e-05	0.000607	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—pancreatic cancer	6.18e-05	0.000593	CcSEcCtD
Carmustine—Hypersensitivity—Irinotecan—pancreatic cancer	6.15e-05	0.000591	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—pancreatic cancer	6.14e-05	0.00059	CcSEcCtD
Carmustine—Convulsion—Docetaxel—pancreatic cancer	6.13e-05	0.000588	CcSEcCtD
Carmustine—GSR—NRF2 pathway—TGFB1—pancreatic cancer	6.12e-05	0.00757	CbGpPWpGaD
Carmustine—Hypertension—Docetaxel—pancreatic cancer	6.11e-05	0.000586	CcSEcCtD
Carmustine—Chest pain—Docetaxel—pancreatic cancer	6.02e-05	0.000578	CcSEcCtD
Carmustine—Myalgia—Docetaxel—pancreatic cancer	6.02e-05	0.000578	CcSEcCtD
Carmustine—Nausea—Sunitinib—pancreatic cancer	6.02e-05	0.000578	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—pancreatic cancer	6.02e-05	0.000578	CcSEcCtD
Carmustine—Renal failure—Epirubicin—pancreatic cancer	6e-05	0.000576	CcSEcCtD
Carmustine—Asthenia—Irinotecan—pancreatic cancer	5.99e-05	0.000575	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—pancreatic cancer	5.99e-05	0.000575	CcSEcCtD
Carmustine—Stomatitis—Epirubicin—pancreatic cancer	5.95e-05	0.000571	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—pancreatic cancer	5.94e-05	0.00057	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—pancreatic cancer	5.93e-05	0.000569	CcSEcCtD
Carmustine—Hypersensitivity—Fluorouracil—pancreatic cancer	5.89e-05	0.000566	CcSEcCtD
Carmustine—Asthenia—Gemcitabine—pancreatic cancer	5.84e-05	0.00056	CcSEcCtD
Carmustine—Confusional state—Docetaxel—pancreatic cancer	5.82e-05	0.000559	CcSEcCtD
Carmustine—Oedema—Docetaxel—pancreatic cancer	5.77e-05	0.000554	CcSEcCtD
Carmustine—GSR—Metabolism—ARG2—pancreatic cancer	5.77e-05	0.00714	CbGpPWpGaD
Carmustine—Infection—Docetaxel—pancreatic cancer	5.74e-05	0.000551	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—pancreatic cancer	5.72e-05	0.000549	CcSEcCtD
Carmustine—Diarrhoea—Irinotecan—pancreatic cancer	5.72e-05	0.000549	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—pancreatic cancer	5.68e-05	0.000546	CcSEcCtD
Carmustine—Thrombocytopenia—Docetaxel—pancreatic cancer	5.65e-05	0.000543	CcSEcCtD
Carmustine—Tachycardia—Docetaxel—pancreatic cancer	5.64e-05	0.000541	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CDKN2A—pancreatic cancer	5.63e-05	0.00697	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen Receptor Pathway—STAT3—pancreatic cancer	5.62e-05	0.00696	CbGpPWpGaD
Carmustine—Diarrhoea—Gemcitabine—pancreatic cancer	5.57e-05	0.000534	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—pancreatic cancer	5.55e-05	0.000533	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	5.54e-05	0.000532	CcSEcCtD
Carmustine—CYP1A2—Melatonin metabolism and effects—APOE—pancreatic cancer	5.54e-05	0.00686	CbGpPWpGaD
Carmustine—Dizziness—Irinotecan—pancreatic cancer	5.52e-05	0.00053	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—pancreatic cancer	5.51e-05	0.000529	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—pancreatic cancer	5.51e-05	0.000529	CcSEcCtD
Carmustine—Anorexia—Docetaxel—pancreatic cancer	5.5e-05	0.000528	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—pancreatic cancer	5.49e-05	0.000527	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—pancreatic cancer	5.48e-05	0.000526	CcSEcCtD
Carmustine—Diarrhoea—Fluorouracil—pancreatic cancer	5.47e-05	0.000525	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—pancreatic cancer	5.46e-05	0.000524	CcSEcCtD
Carmustine—Oedema peripheral—Epirubicin—pancreatic cancer	5.4e-05	0.000518	CcSEcCtD
Carmustine—Hypotension—Docetaxel—pancreatic cancer	5.4e-05	0.000518	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—pancreatic cancer	5.39e-05	0.000517	CcSEcCtD
Carmustine—Vomiting—Irinotecan—pancreatic cancer	5.31e-05	0.00051	CcSEcCtD
Carmustine—Dizziness—Fluorouracil—pancreatic cancer	5.29e-05	0.000508	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—pancreatic cancer	5.28e-05	0.000507	CcSEcCtD
Carmustine—Rash—Irinotecan—pancreatic cancer	5.27e-05	0.000506	CcSEcCtD
Carmustine—Dermatitis—Irinotecan—pancreatic cancer	5.26e-05	0.000505	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	5.26e-05	0.000505	CcSEcCtD
Carmustine—Headache—Irinotecan—pancreatic cancer	5.23e-05	0.000502	CcSEcCtD
Carmustine—Insomnia—Docetaxel—pancreatic cancer	5.22e-05	0.000501	CcSEcCtD
Carmustine—Paraesthesia—Docetaxel—pancreatic cancer	5.19e-05	0.000498	CcSEcCtD
Carmustine—Vomiting—Gemcitabine—pancreatic cancer	5.17e-05	0.000497	CcSEcCtD
Carmustine—Dyspnoea—Docetaxel—pancreatic cancer	5.15e-05	0.000494	CcSEcCtD
Carmustine—Somnolence—Docetaxel—pancreatic cancer	5.13e-05	0.000493	CcSEcCtD
Carmustine—Rash—Gemcitabine—pancreatic cancer	5.13e-05	0.000492	CcSEcCtD
Carmustine—Dermatitis—Gemcitabine—pancreatic cancer	5.13e-05	0.000492	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—pancreatic cancer	5.12e-05	0.000492	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CXCL8—pancreatic cancer	5.11e-05	0.00632	CbGpPWpGaD
Carmustine—Haemoglobin—Doxorubicin—pancreatic cancer	5.1e-05	0.000489	CcSEcCtD
Carmustine—Headache—Gemcitabine—pancreatic cancer	5.1e-05	0.000489	CcSEcCtD
Carmustine—Flushing—Epirubicin—pancreatic cancer	5.09e-05	0.000488	CcSEcCtD
Carmustine—Vomiting—Fluorouracil—pancreatic cancer	5.09e-05	0.000488	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—pancreatic cancer	5.07e-05	0.000487	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—pancreatic cancer	5.05e-05	0.000484	CcSEcCtD
Carmustine—Rash—Fluorouracil—pancreatic cancer	5.04e-05	0.000484	CcSEcCtD
Carmustine—Dermatitis—Fluorouracil—pancreatic cancer	5.04e-05	0.000484	CcSEcCtD
Carmustine—GSR—Metabolism—TYMP—pancreatic cancer	5.04e-05	0.00624	CbGpPWpGaD
Carmustine—Decreased appetite—Docetaxel—pancreatic cancer	5.02e-05	0.000482	CcSEcCtD
Carmustine—Headache—Fluorouracil—pancreatic cancer	5.01e-05	0.000481	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—pancreatic cancer	5e-05	0.00048	CcSEcCtD
Carmustine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	4.99e-05	0.000479	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—pancreatic cancer	4.99e-05	0.000478	CcSEcCtD
Carmustine—Nausea—Irinotecan—pancreatic cancer	4.96e-05	0.000476	CcSEcCtD
Carmustine—Constipation—Docetaxel—pancreatic cancer	4.94e-05	0.000474	CcSEcCtD
Carmustine—Pain—Docetaxel—pancreatic cancer	4.94e-05	0.000474	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—pancreatic cancer	4.9e-05	0.00047	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—pancreatic cancer	4.89e-05	0.000469	CcSEcCtD
Carmustine—Alopecia—Epirubicin—pancreatic cancer	4.84e-05	0.000465	CcSEcCtD
Carmustine—Nausea—Gemcitabine—pancreatic cancer	4.83e-05	0.000464	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—pancreatic cancer	4.8e-05	0.000461	CcSEcCtD
Carmustine—Erythema—Epirubicin—pancreatic cancer	4.77e-05	0.000458	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—pancreatic cancer	4.77e-05	0.000458	CcSEcCtD
Carmustine—Feeling abnormal—Docetaxel—pancreatic cancer	4.76e-05	0.000457	CcSEcCtD
Carmustine—Nausea—Fluorouracil—pancreatic cancer	4.75e-05	0.000456	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—pancreatic cancer	4.74e-05	0.000455	CcSEcCtD
Carmustine—Gastrointestinal pain—Docetaxel—pancreatic cancer	4.72e-05	0.000453	CcSEcCtD
Carmustine—Flushing—Doxorubicin—pancreatic cancer	4.71e-05	0.000452	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—pancreatic cancer	4.68e-05	0.00579	CbGpPWpGaD
Carmustine—Back pain—Epirubicin—pancreatic cancer	4.62e-05	0.000443	CcSEcCtD
Carmustine—Abdominal pain—Docetaxel—pancreatic cancer	4.57e-05	0.000438	CcSEcCtD
Carmustine—Body temperature increased—Docetaxel—pancreatic cancer	4.57e-05	0.000438	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—pancreatic cancer	4.53e-05	0.000435	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—pancreatic cancer	4.5e-05	0.000432	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—pancreatic cancer	4.48e-05	0.00043	CcSEcCtD
Carmustine—Mental disorder—Doxorubicin—pancreatic cancer	4.44e-05	0.000427	CcSEcCtD
Carmustine—Erythema—Doxorubicin—pancreatic cancer	4.42e-05	0.000424	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—pancreatic cancer	4.42e-05	0.000424	CcSEcCtD
Carmustine—Anaemia—Epirubicin—pancreatic cancer	4.41e-05	0.000423	CcSEcCtD
Carmustine—Agitation—Epirubicin—pancreatic cancer	4.39e-05	0.000421	CcSEcCtD
Carmustine—Leukopenia—Epirubicin—pancreatic cancer	4.27e-05	0.00041	CcSEcCtD
Carmustine—Back pain—Doxorubicin—pancreatic cancer	4.27e-05	0.00041	CcSEcCtD
Carmustine—Hypersensitivity—Docetaxel—pancreatic cancer	4.25e-05	0.000408	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	4.25e-05	0.00526	CbGpPWpGaD
Carmustine—Vision blurred—Doxorubicin—pancreatic cancer	4.16e-05	0.000399	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—VEGFA—pancreatic cancer	4.15e-05	0.00514	CbGpPWpGaD
Carmustine—Asthenia—Docetaxel—pancreatic cancer	4.14e-05	0.000398	CcSEcCtD
Carmustine—Convulsion—Epirubicin—pancreatic cancer	4.14e-05	0.000397	CcSEcCtD
Carmustine—Hypertension—Epirubicin—pancreatic cancer	4.12e-05	0.000396	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—STAT3—pancreatic cancer	4.11e-05	0.00509	CbGpPWpGaD
Carmustine—Anaemia—Doxorubicin—pancreatic cancer	4.08e-05	0.000392	CcSEcCtD
Carmustine—Chest pain—Epirubicin—pancreatic cancer	4.06e-05	0.00039	CcSEcCtD
Carmustine—Myalgia—Epirubicin—pancreatic cancer	4.06e-05	0.00039	CcSEcCtD
Carmustine—GSR—Metabolism—GLP1R—pancreatic cancer	4.06e-05	0.00503	CbGpPWpGaD
Carmustine—Agitation—Doxorubicin—pancreatic cancer	4.06e-05	0.00039	CcSEcCtD
Carmustine—Anxiety—Epirubicin—pancreatic cancer	4.05e-05	0.000389	CcSEcCtD
Carmustine—GSR—Metabolism—DPYD—pancreatic cancer	4e-05	0.00495	CbGpPWpGaD
Carmustine—Leukopenia—Doxorubicin—pancreatic cancer	3.95e-05	0.000379	CcSEcCtD
Carmustine—Diarrhoea—Docetaxel—pancreatic cancer	3.95e-05	0.000379	CcSEcCtD
Carmustine—Confusional state—Epirubicin—pancreatic cancer	3.93e-05	0.000377	CcSEcCtD
Carmustine—Oedema—Epirubicin—pancreatic cancer	3.9e-05	0.000374	CcSEcCtD
Carmustine—Infection—Epirubicin—pancreatic cancer	3.87e-05	0.000371	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—pancreatic cancer	3.83e-05	0.000367	CcSEcCtD
Carmustine—Dizziness—Docetaxel—pancreatic cancer	3.82e-05	0.000367	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—pancreatic cancer	3.81e-05	0.000366	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—pancreatic cancer	3.81e-05	0.000366	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—pancreatic cancer	3.8e-05	0.000365	CcSEcCtD
Carmustine—GSR—Metabolism—SLC2A2—pancreatic cancer	3.79e-05	0.0047	CbGpPWpGaD
Carmustine—Chest pain—Doxorubicin—pancreatic cancer	3.76e-05	0.000361	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—pancreatic cancer	3.76e-05	0.000361	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—pancreatic cancer	3.75e-05	0.00036	CcSEcCtD
Carmustine—Anorexia—Epirubicin—pancreatic cancer	3.71e-05	0.000356	CcSEcCtD
Carmustine—Vomiting—Docetaxel—pancreatic cancer	3.67e-05	0.000352	CcSEcCtD
Carmustine—Rash—Docetaxel—pancreatic cancer	3.64e-05	0.000349	CcSEcCtD
Carmustine—Hypotension—Epirubicin—pancreatic cancer	3.64e-05	0.000349	CcSEcCtD
Carmustine—Dermatitis—Docetaxel—pancreatic cancer	3.64e-05	0.000349	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—pancreatic cancer	3.63e-05	0.000349	CcSEcCtD
Carmustine—Headache—Docetaxel—pancreatic cancer	3.62e-05	0.000347	CcSEcCtD
Carmustine—Oedema—Doxorubicin—pancreatic cancer	3.6e-05	0.000346	CcSEcCtD
Carmustine—Infection—Doxorubicin—pancreatic cancer	3.58e-05	0.000344	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	3.55e-05	0.000341	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—pancreatic cancer	3.53e-05	0.000339	CcSEcCtD
Carmustine—Insomnia—Epirubicin—pancreatic cancer	3.52e-05	0.000338	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—pancreatic cancer	3.52e-05	0.000338	CcSEcCtD
Carmustine—Paraesthesia—Epirubicin—pancreatic cancer	3.5e-05	0.000336	CcSEcCtD
Carmustine—Dyspnoea—Epirubicin—pancreatic cancer	3.47e-05	0.000333	CcSEcCtD
Carmustine—Somnolence—Epirubicin—pancreatic cancer	3.46e-05	0.000332	CcSEcCtD
Carmustine—Anorexia—Doxorubicin—pancreatic cancer	3.44e-05	0.00033	CcSEcCtD
Carmustine—Nausea—Docetaxel—pancreatic cancer	3.43e-05	0.000329	CcSEcCtD
Carmustine—Decreased appetite—Epirubicin—pancreatic cancer	3.39e-05	0.000325	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—pancreatic cancer	3.37e-05	0.000323	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	3.36e-05	0.000323	CcSEcCtD
Carmustine—Constipation—Epirubicin—pancreatic cancer	3.33e-05	0.00032	CcSEcCtD
Carmustine—Pain—Epirubicin—pancreatic cancer	3.33e-05	0.00032	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	3.28e-05	0.000315	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—pancreatic cancer	3.26e-05	0.000313	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—pancreatic cancer	3.24e-05	0.000311	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—pancreatic cancer	3.21e-05	0.000308	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—pancreatic cancer	3.21e-05	0.000308	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—pancreatic cancer	3.2e-05	0.000308	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	3.19e-05	0.00395	CbGpPWpGaD
Carmustine—Gastrointestinal pain—Epirubicin—pancreatic cancer	3.19e-05	0.000306	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—pancreatic cancer	3.13e-05	0.00388	CbGpPWpGaD
Carmustine—Decreased appetite—Doxorubicin—pancreatic cancer	3.13e-05	0.000301	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	3.11e-05	0.000299	CcSEcCtD
Carmustine—Constipation—Doxorubicin—pancreatic cancer	3.08e-05	0.000296	CcSEcCtD
Carmustine—Pain—Doxorubicin—pancreatic cancer	3.08e-05	0.000296	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—pancreatic cancer	3.08e-05	0.000296	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—pancreatic cancer	3.08e-05	0.000296	CcSEcCtD
Carmustine—Feeling abnormal—Doxorubicin—pancreatic cancer	2.97e-05	0.000285	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	2.95e-05	0.000283	CcSEcCtD
Carmustine—GSR—Metabolism—CD44—pancreatic cancer	2.94e-05	0.00364	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—pancreatic cancer	2.87e-05	0.000275	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—pancreatic cancer	2.85e-05	0.000273	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—pancreatic cancer	2.85e-05	0.000273	CcSEcCtD
Carmustine—GSR—Metabolism—GCG—pancreatic cancer	2.82e-05	0.00349	CbGpPWpGaD
Carmustine—Asthenia—Epirubicin—pancreatic cancer	2.79e-05	0.000268	CcSEcCtD
Carmustine—Diarrhoea—Epirubicin—pancreatic cancer	2.67e-05	0.000256	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—pancreatic cancer	2.66e-05	0.000255	CcSEcCtD
Carmustine—GSR—Metabolism—STK11—pancreatic cancer	2.65e-05	0.00328	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—pancreatic cancer	2.62e-05	0.00325	CbGpPWpGaD
Carmustine—Asthenia—Doxorubicin—pancreatic cancer	2.59e-05	0.000248	CcSEcCtD
Carmustine—Dizziness—Epirubicin—pancreatic cancer	2.58e-05	0.000247	CcSEcCtD
Carmustine—Vomiting—Epirubicin—pancreatic cancer	2.48e-05	0.000238	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—pancreatic cancer	2.47e-05	0.000237	CcSEcCtD
Carmustine—Rash—Epirubicin—pancreatic cancer	2.46e-05	0.000236	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—pancreatic cancer	2.45e-05	0.00304	CbGpPWpGaD
Carmustine—Dermatitis—Epirubicin—pancreatic cancer	2.45e-05	0.000236	CcSEcCtD
Carmustine—Headache—Epirubicin—pancreatic cancer	2.44e-05	0.000234	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—pancreatic cancer	2.38e-05	0.000229	CcSEcCtD
Carmustine—Nausea—Epirubicin—pancreatic cancer	2.31e-05	0.000222	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—pancreatic cancer	2.29e-05	0.00022	CcSEcCtD
Carmustine—GSR—Metabolism—TYMS—pancreatic cancer	2.28e-05	0.00282	CbGpPWpGaD
Carmustine—Rash—Doxorubicin—pancreatic cancer	2.27e-05	0.000218	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—pancreatic cancer	2.27e-05	0.000218	CcSEcCtD
Carmustine—Headache—Doxorubicin—pancreatic cancer	2.26e-05	0.000217	CcSEcCtD
Carmustine—Nausea—Doxorubicin—pancreatic cancer	2.14e-05	0.000205	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—pancreatic cancer	2.12e-05	0.00263	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	2.12e-05	0.00263	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	2.07e-05	0.00256	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	2.04e-05	0.00253	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	1.9e-05	0.00235	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—pancreatic cancer	1.9e-05	0.00235	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—pancreatic cancer	1.86e-05	0.0023	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	1.86e-05	0.0023	CbGpPWpGaD
Carmustine—GSR—Metabolism—APOE—pancreatic cancer	1.85e-05	0.00229	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—pancreatic cancer	1.77e-05	0.00219	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	1.77e-05	0.00219	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	1.76e-05	0.00217	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CG—pancreatic cancer	1.67e-05	0.00207	CbGpPWpGaD
Carmustine—GSR—Metabolism—PPARG—pancreatic cancer	1.61e-05	0.002	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	1.49e-05	0.00185	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CD—pancreatic cancer	1.47e-05	0.00182	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CB—pancreatic cancer	1.28e-05	0.00159	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—pancreatic cancer	1.27e-05	0.00157	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTEN—pancreatic cancer	1.11e-05	0.00137	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PRSS1—pancreatic cancer	8.18e-06	0.00101	CbGpPWpGaD
Carmustine—GSR—Metabolism—PIK3CA—pancreatic cancer	7.81e-06	0.000967	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ARG2—pancreatic cancer	7.1e-06	0.000879	CbGpPWpGaD
Carmustine—GSR—Metabolism—AKT1—pancreatic cancer	6.38e-06	0.00079	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TYMP—pancreatic cancer	6.2e-06	0.000768	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5.12e-06	0.000634	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GLP1R—pancreatic cancer	5e-06	0.000619	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—DPYD—pancreatic cancer	4.92e-06	0.000609	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—SLC2A2—pancreatic cancer	4.67e-06	0.000578	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.62e-06	0.000572	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.46e-06	0.000552	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.06e-06	0.000503	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CD44—pancreatic cancer	3.61e-06	0.000448	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.54e-06	0.000438	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.51e-06	0.000434	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GCG—pancreatic cancer	3.47e-06	0.000429	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—STK11—pancreatic cancer	3.26e-06	0.000403	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.06e-06	0.000379	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—TYMS—pancreatic cancer	2.8e-06	0.000347	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—APOE—pancreatic cancer	2.28e-06	0.000282	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.16e-06	0.000267	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	2.06e-06	0.000255	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PPARG—pancreatic cancer	1.99e-06	0.000246	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	1.81e-06	0.000224	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	1.58e-06	0.000195	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—pancreatic cancer	1.56e-06	0.000193	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTEN—pancreatic cancer	1.36e-06	0.000169	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	9.61e-07	0.000119	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—AKT1—pancreatic cancer	7.85e-07	9.72e-05	CbGpPWpGaD
